United States Securities and Exchange Commission · EDGAR Accession 0001787792-26-000007

Form C-AR/A

Annual Report Amendment — Regulation Crowdfunding
Issuer CIK 1787792
Period 2025-12-31

Fisher Wallace Laboratories, Inc.

CorporationDEIncorporated 2019BROOKLYN, NYfisherwallace.com
B

Financial Condition

two fiscal years, as filed
Revenue −28% YoYBurn decreasingDebt / assets 888%3 employees
Line itemMost recent FYPrior FYΔ
Revenue34,26147,412▼ 28%
Cost of goods sold5,0493,012▲ 68%
Net income(1,447,538)(1,579,900)▲ burn
Total assets144,634154,382▼ 6%
Cash & equivalents48,14241,626▲ 16%
Accounts receivable00
Short-term debt591,311596,721▼ 1%
Long-term debt693,612925,582▼ 25%
Taxes paid00

Figures in USD as reported by the issuer.